Similar articles

• Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules.

  Qiu X, Mistry A, Ammirati MJ, Chrunyk BA, Clark RW, Cong Y, Culp JS, Danley DE, Freeman TB, Geoghegan KF, Griffor MC, Hawrylik SJ, Hayward CM, Hensley P, Hoth LR, Karam GA, Lira ME, Lloyd DB, McGrath KM, Stutzman-Engwall KJ, Subashi AK, Subashi TA, Thompson JF, Wang IK, Zhao H, Seddon AP. Qiu X, et al. Nat Struct Mol Biol. 2007 Feb;14(2):106-13. doi: 10.1038/nsmb1197. Epub 2007 Jan 21. Nat Struct Mol Biol. 2007. PMID: 17237796
• Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction.

  Schaefer EJ, Asztalos BF. Schaefer EJ, et al. Am J Cardiol. 2007 Dec 3;100(11 A):n25-31. doi: 10.1016/j.amjcard.2007.08.010. Am J Cardiol. 2007. PMID: 18047849 Review.
• Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.

  Rano TA, Sieber-McMaster E, Pelton PD, Yang M, Demarest KT, Kuo GH. Rano TA, et al. Bioorg Med Chem Lett. 2009 May 1;19(9):2456-60. doi: 10.1016/j.bmcl.2009.03.051. Epub 2009 Mar 18. Bioorg Med Chem Lett. 2009. PMID: 19339179
• Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.

  Seiler S, Schlitt A, Jiang XC, Ulrich C, Blankenberg S, Lackner KJ, Girndt M, Werdan K, Buerke M, Fliser D, Heine GH. Seiler S, et al. Nephrol Dial Transplant. 2008 Nov;23(11):3599-604. doi: 10.1093/ndt/gfn296. Epub 2008 May 25. Nephrol Dial Transplant. 2008. PMID: 18503096
• Vaccines for the prevention of cardiovascular disease.

  Ryan US, Rittershaus CW. Ryan US, et al. Vascul Pharmacol. 2006 Nov;45(5):253-7. doi: 10.1016/j.vph.2006.08.004. Epub 2006 Aug 17. Vascul Pharmacol. 2006. PMID: 17046334 Review.